76 Participants Needed

Neuroeconomic Decision-Making for Alcoholism

MA
Overseen ByMichael Amlung, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This study uses techniques from an area of research known as neuroeconomics, which integrates concepts and methods from psychology, neuroscience, and economics to better understand how people make decisions and how these decisions are supported by the brain. One neuroeconomic concept that is especially relevant in the area of addictions is substance demand, or how consumption of a commodity (e.g., alcohol, tobacco, or drugs) is influenced by price and other factors. Previous studies have shown that alcohol demand is related to severity of alcohol misuse, drinking quantity/frequency, and treatment outcomes. In addition, we know that alcohol demand can also fluctuate in response to environmental cues such as alcohol-related stimuli or external contingencies such as important responsibilities the following day. These increase and decreases in consumption and value are clinically significant because they help us understand how people with alcohol use disorders are able to successfully or unsuccessfully modulate their drinking behaviors. This study is examining how the brain responds in these situations and whether these responses differ as a function of severity of alcohol misuse. This study will use functional magnetic resonance imaging (fMRI) to understand brain activity patterns associated with changes in the value of alcohol in the presence of alcohol-related beverage cues relative to neutral-related beverage cue. Participants will be non-treatment-seeking adult heavy drinkers who are recruited from the community to participate in an fMRI scan. During the scan, participants will make decisions about how many alcohol beverages they would consume (hypothetically) at various prices while their brain activity during those decisions is measured. The first experimental manipulation involves an in-scanner alcohol cue exposure task in which the drinking decisions will be made after viewing high-quality images of alcoholic (beer/wine/liquor) beverages or neutral (water/juice/soft drinks) beverages.

Research Team

MA

Michael Amlung, PhD

Principal Investigator

University of Kansas

Eligibility Criteria

This trial is for right-handed, English-speaking adults aged 21-55 who drink heavily (more than 14/7 drinks per week for males/females) and have at least one heavy drinking episode weekly. It's not for those seeking alcohol treatment, with other substance use disorders (except tobacco), frequent recreational drug use, certain mental health conditions, brain injuries, or MRI contraindications like metal implants.

Inclusion Criteria

21-55 years old
Right-handed
Fluent English speaker
See 2 more

Exclusion Criteria

Weekly or more frequent use of recreational drugs
Currently receiving treatment, or seeking treatment, for alcohol related problems
Current Diagnostic and Statistical Manual (DSM-5) substance use disorder other than alcohol or tobacco
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Experimental Manipulation

Participants undergo an in-scanner alcohol cue exposure task, making decisions about alcohol consumption at various prices while brain activity is measured

1 hour
1 visit (in-person, MRI scan)

Follow-up

Participants are monitored for safety and effectiveness after the experimental manipulation

4 weeks

Treatment Details

Interventions

  • Alcohol cue
  • Neutral cue
Trial Overview The study tests how the brain values alcohol when exposed to alcohol-related cues versus neutral ones using fMRI scans. Participants will make hypothetical choices about alcohol consumption at different prices while their brain activity is monitored after seeing images of alcoholic or non-alcoholic beverages.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Alcohol CueExperimental Treatment1 Intervention
Alcohol cue exposure in scanner
Group II: Neutral CueActive Control1 Intervention
Neutral cue exposure in scanner

Find a Clinic Near You

Who Is Running the Clinical Trial?

McMaster University

Lead Sponsor

Trials
936
Recruited
2,630,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security